Hemojuvelin and bone morphogenetic protein (BMP) signaling in iron homeostasis

Front Pharmacol. 2014 May 13:5:104. doi: 10.3389/fphar.2014.00104. eCollection 2014.

Abstract

Mutations in hemojuvelin (HJV) are the most common cause of the juvenile-onset form of the iron overload disorder hereditary hemochromatosis. The discovery that HJV functions as a co-receptor for the bone morphogenetic protein (BMP) family of signaling molecules helped to identify this signaling pathway as a central regulator of the key iron hormone hepcidin in the control of systemic iron homeostasis. This review highlights recent work uncovering the mechanism of action of HJV and the BMP-SMAD signaling pathway in regulating hepcidin expression in the liver, as well as additional studies investigating possible extra-hepatic functions of HJV. This review also explores the interaction between HJV, the BMP-SMAD signaling pathway and other regulators of hepcidin expression in systemic iron balance.

Keywords: bone morphogenetic protein; hemochromatosis; hemojuvelin; hepcidin; iron; repulsive guidance molecule.

Publication types

  • Review